Skip to content
10-Q

Quarterly Report

Lomond Therapeutics Holdings, Inc.

0001213900-24-091191

← back to feed
Filed
Oct 28, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Oct 28, 2024 5M sh
Current Liabilities Q3 2024 · Sep 30, 2024 $138.2K
Current Liabilities Q3 2024 · Dec 31, 2023 $103.2K
Total Liabilities Q3 2024 · Sep 30, 2024 $138.2K
Total Liabilities Q3 2024 · Dec 31, 2023 $103.2K
Current Assets Q3 2024 · Sep 30, 2024 $2.27K
Current Assets Q3 2024 · Dec 31, 2023 $984
Total Assets Q3 2024 · Sep 30, 2024 $2.27K
Total Assets Q3 2024 · Dec 31, 2023 $984
Net Income Q3 2024 · Jun 30, 2024 −$11.47K
Net Income Q3 2024 · Mar 31, 2024 −$11.29K
Net Income Q3 2024 · Sep 30, 2023 −$10.87K
Net Income Q3 2024 · Sep 30, 2023 −$36.83K
Net Income Q3 2024 · Jun 30, 2023 −$12.83K
Net Income Q3 2024 · Mar 31, 2023 −$13.13K
Stockholders Equity Q3 2024 · Mar 31, 2024 −$113.51K
Stockholders Equity Q3 2024 · Sep 30, 2023 −$91.11K
Stockholders Equity Q3 2024 · Jun 30, 2023 −$80.24K
Stockholders Equity Q3 2024 · Mar 31, 2023 −$67.41K
Stockholders Equity Q3 2024 · Dec 31, 2022 −$54.28K
Shares Diluted Q3 2024 · Sep 30, 2023 5M sh
Shares Diluted Q3 2024 · Sep 30, 2023 5M sh
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$35.49K
Eps Diluted Q3 2024 · Sep 30, 2023 $0.00
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.01
Eps Basic Q3 2024 · Sep 30, 2023 $0.00
Eps Basic Q3 2024 · Sep 30, 2023 −$0.01
Sga Expense Q3 2024 · Sep 30, 2023 $10.87K
Sga Expense Q3 2024 · Sep 30, 2023 $36.83K
Operating Income Q3 2024 · Sep 30, 2023 −$10.87K
Operating Income Q3 2024 · Sep 30, 2023 −$36.83K